NCT00976560 - Clinical Study to Test a New Drug to Treat Major Depression | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

September 25, 2009

Primary Completion Date

July 7, 2010

Study Completion Date

July 7, 2010

Conditions

Depressive Disorder, Major

Interventions

DRUG

GW856553

Wet Granulated, film coated white, 9mm round, biconvex, plain faced tablets, containing 7.5 mg of GW856553

OTHER

Placebo

Film coated white, 9mm round, biconvex, plain faced tablets obtained by direct compression.

Trial Locations (21)

1113

GSK Investigational Site, Sofia

4000

GSK Investigational Site, Plovdiv

4400

GSK Investigational Site, Pazardzhik

10128

GSK Investigational Site, New York

10629

GSK Investigational Site, Berlin

19053

GSK Investigational Site, Schwerin

26655

GSK Investigational Site, Westerstede

28832

GSK Investigational Site, Achim

33647

GSK Investigational Site, Bielefeld

35625

GSK Investigational Site, Hüttenberg

43210

GSK Investigational Site, Columbus

50417

GSK Investigational Site, Tartu

60068

GSK Investigational Site, Park Ridge

60169

GSK Investigational Site, Hoffman Estates

107076

GSK Investigational Site, Moscow

125367

GSK Investigational Site, Moscow

443016

GSK Investigational Site, Samara

Unknown

GSK Investigational Site, Rousse

GSK Investigational Site, Saint Petersburg

01097

GSK Investigational Site, Dresden

214 019

GSK Investigational Site, Smolensk